InterMune Inc (ITMN)

ITMN (NASDAQ:Drugs)
$73.89
neg -0.02
-0.03%
Today's Range: 73.81 - 73.99 | ITMN Avg Daily Volume: 3,940,800
Last Update: 09/26/14 - 4:00 PM EDT
Volume: 5,721,727
YTD Performance: 401.63%
Open: $73.91
Previous Close: $73.91
52 Week Range: $10.95 - $74.24
Oustanding Shares: 107,969,163
Market Cap: 7,977,841,454
6-Month Chart
TheStreet Ratings Grade for ITMN
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 4 4 7 8
Moderate Buy 0 0 0 0
Hold 6 6 1 2
Moderate Sell 0 0 1 1
Strong Sell 0 0 0 0
Mean Rec. 2.20 2.20 1.56 1.64
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: -28.42
Price Earnings Comparisons:
ITMN Sector Avg. S&P 500
-28.42 0.00 27.99
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
67.82% 393.59% 241.14%
GROWTH 12 Mo 3 Yr CAGR
Revenue 2.10 -0.46 -0.19
Net Income 0.00 0.59 0.00
EPS 0.00 -0.12 0.00
Earnings for ITMN:
EBITDA -0.19B
Revenue 0.03B
Average Earnings Estimates
Qtr (09/14) Qtr (12/14) FY (12/14) FY (12/15)
Average Estimate $-0.68 $-0.76 $-2.72 $-1.39
Number of Analysts 9 9 10 10
High Estimate $-0.53 $-0.59 $-2.23 $-0.16
Low Estimate $-0.75 $-0.82 $-2.89 $-2.02
Prior Year $-0.62 $-0.67 $-2.72 $-2.72
Growth Rate (Year over Year) -9.14% -13.76% 0.04% 48.77%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
The Burger King deal exemplifies companies helping themselves and the index.
The acquisition is a symbol of a much bigger trend.
French government resigns; German business confidence falls.
Bearish
Aug 21, 2014 | 7:19 AM EDT
ITMN was downgraded from Outperform to Market Perform, Wells Fargo said. Valuation call, as a potential takeover premium is largely bak...
Bearish
Aug 14, 2014 | 6:54 AM EDT
ITMN was downgraded from Buy to Neutral, Goldman Sachs said. Valuation call, based on a $49 price target.
Don't batten down the hatches yet.
Bullish
May 19, 2014 | 8:15 AM EDT
ITMN was upgraded from Market Perform to Outperform, Leerink Swann said. $41 price target. Company posted better clinical data in two t...
Bearish
Feb 28, 2014 | 8:09 AM EST
ITMN was downgraded from Outperform to Neutral, Credit Suisse said. Valuation call, based on a $33 price target. 
Bearish
Feb 26, 2014 | 7:57 AM EST
ITMN was downgraded from Outperform to Market Perform, Leerink Swann said. Valuation call, based on a $41 price target. 
InterMune, Novavax have promising products and acquisition possibilities.

Columnist Conversations

HP
Multiple downside targets have been met in HP....either trail stops down or book some profits or BOTH. ...
What an ugly short session for oil and energy related stocks. Think we get some sort of bounce on Monday when...
I saw a comment on JC's piece asking about a tariff on crude oil to protect the American industry and a respon...
Lang:
i was double-delighted to see Stephanie Link bullish on LULU but also a recent piece by Ed Ponsi reflecting th...

REAL MONEY'S BEST IDEAS

Columnist Tweets

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.